Premium storiesSee all

Don't missSee all

Endpoints Standouts

Peer review See all

R&D channel feed

Pharma channel feed

Coronavirus channel feed

3 days ago

With a med­ley of ad­verse events hob­bling the late-stage de­vel­op­ment of vac­cines and drugs, Pfiz­er CEO Al­bert Bourla’s lat­est — ex­tend­ed — time­line for the mR­NA ap­proach ...